Company
Precede Biosciences
| Industry | biotechnology company providing a blood-based approach to revealing disease-defining transcriptional biology, emerged from stealth with $57M in funding since inception |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Precede Biosciences | Investment | 2023-10-10 |